Verrica Pharmaceuticals Inc. (VRCA) Shareholders’ equity 2021–2025
Verrica Pharmaceuticals Inc. (VRCA) shareholders’ equity at each fiscal year-end, per SEC filings.
$24.7MFY2025 · since FY2021: $32.6M → $24.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $24.7M | +350.9% |
| FY2024 | -$9.9M | -149.9% |
| FY2023 | $19.8M | -50.6% |
| FY2022 | $40.0M | +22.8% |
| FY2021 | $32.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice